Jennison Associates
STJ

Jennison Associates’s St Jude Medical STJ Stock Holding History

Jennison Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,609
Closed -$370K – 854
2016
Q4 		$370K Buy
+4,609
New +$366K ﹤0.01% 710
2015
Q4 		– Sell
-9,774
Closed -$617K – 768
2015
Q3 		$617K Buy
+9,774
New +$698K ﹤0.01% 657
2014
Q3 		– Sell
-22,532
Closed -$1.56M – 773
2014
Q2 		$1.56M Buy
+22,532
New +$1.46M ﹤0.01% 590
2014
Q1 		– Sell
-552,343
Closed -$34.2M – 806
2013
Q4 		$34.2M Buy
+552,343
New +$32M 0.03% 381

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Jennison Associates's STJ Position: Q1 2017 in Review

Jennison Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,609 shares — an estimated $370K sold.

Jennison Associates first reported a position in STJ in Q4 2013 and held it in 4 quarters. The position peaked at $34.2M in Q4 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Jennison Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Jennison Associates sold 4,609 St Jude Medical shares in Q1 2017, an estimated $370K.
  • Jennison Associates first reported a position in St Jude Medical in Q4 2013 and held it in 4 quarters.
  • Jennison Associates's St Jude Medical position peaked at $34.2M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.